Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

Jin Medical International (NASDAQ:ZJYL) shares jumped 63.41% to $3.17 in after-hours after it reported unaudited six-month results ended Mar. 31. Revenue fell 9.7% to $8.9M. Gross margin rose to 26.9% from 24.3%, net loss was $0.2M, and it held $9.1M cash plus $21M short-term investments.

JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) reported unaudited results for the six months ended March 31, 2026. Revenue fell 9.7% to $8.9 million. Gross margin rose to 26.9% and net loss was $0.2 million. Cash was $9.1 million plus $21.0 million short-term investments. Wheelchair revenue was stable; foreign exchange pressure from Nissin was cited.

Zhongji Innolight, a Chinese optical transceiver maker, began trading on Hong Kong’s exchange and shares fell about 5%. The company raised HK$53.4 billion (about $6.8 billion) in an IPO priced at HK$980 per share, below the HK$1,010 top of the range. It supplies AI data center and networking components and plans to fund R&D and capacity expansion.

JPMorgan Chase (NYSE: JPM) plans to invest $750 billion in housing through 2035, a 40% increase from the past decade, to address the U.S. housing shortage. The investment aims to build or preserve 1 million affordable housing units and assist 500,000 homebuyers. The bank will increase mortgage lending by 40% and hire 850 new home lending advisors. According to Zillow, the U.S. faces a housing shortage of up to 4.7 million homes, with median home prices at a record $440,600 and average 30-year mo

Meta Platforms (META) agreed to a $17 billion settlement for teen social media safety concerns, pending court approval. The deal includes fines and platform changes like daily use limits. Analysts expect minimal impact on teen usage and revenue, maintaining a $850 fair value estimate. Meta's AI investments remain a focus for investors.

JPMorgan Chase (JPM) is relaxing its lending rules for shares of newly listed companies like SpaceX (SPCX), allowing loans against them before the usual 135-day waiting period. This move aims to capture wealth from the AI boom. JPMorgan earned $75 million from the SpaceX listing. The bank assesses liquidity and price discovery for lending decisions. Lending against newly listed stocks carries risks, including price volatility and limited trading volumes.